GOULD ROBERT J (See Remarks) sold 3.1% of their position (15K shares) of FULCRUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $178.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/6/2026ACC: 0001193125-26-004572
DirectorOfficer10% Owner· See Remarks
Since Jul 2019
-15K
Net shares
Net seller
$178.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
$11.87
Trade value
$178.09K
% of position
3.1%
1/2/2026
484.86K→469.86K
Total
Net shares
−15K
Net value
-$178.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −15K | $11.87 | $178.09K | 3.1% | 484.86K | 469.86K |
| Total | −15K | -$178.09K | ||||||
Derivative Transactions0
No derivative transactions reported